Table 1.
Characteristics of all patients.
| Characteristics | All patients (N = 359) |
|---|---|
| Underlying diseases | |
| AML | 237 |
| ALL | 112 |
| MAL | 10 |
| Gender | |
| Male | 198 |
| Female | 161 |
| Risk stratification | |
| High | 166 |
| Standard | 193 |
| Disease status | |
| Non-CR | 40 |
| CR | 319 |
| Donor type | |
| HRD | 195 |
| MSD | 164 |
| Donor/recipient serostatus | |
| D+/R+ | 311 |
| D−/R+ | 19 |
| D+/R− | 11 |
| D−/R− | 0 |
| Graft | |
| PBSC | 340 |
| BM+PBSC | 19 |
| Age (y) | 34.00 (3–58) |
| MNC (×108/kg) | 10.00 (3.21–25.63) |
| CD34+ cells (×106/kg) | 2.81 (1.3–19.76) |
ALL = acute lymphocytic leukemia, AML = acute myeloid leukemia, BM = bone marrow, CR = complete remission, HRD = haploidentical-related donor, MAL = mixed acute leukemia, MNC = mononuclear cell, MSD = matched sibling donor, PBSC = peripheral blood stem cell.